A5093342768- Hepatitis C virus research
- HIV, Drug Use, Sexual Risk
- Liver Disease Diagnosis and Treatment
- HIV/AIDS Research and Interventions
- Hepatitis B Virus Studies
New York University
2024
Johns Hopkins University
2023-2024
Abstract Background Sixty-eight percent of the nearly 3.5 million people living with hepatitis C virus (HCV) in United States are who inject drugs (PWID). Despite effective treatments, uptake remains low PWID. We examined social determinants health (SDoH) that affect HCV care cascade. Methods conducted a secondary analysis data from 720 PWID cluster-randomized trial. recruited 12 drug-affected areas Baltimore. Inclusion criteria were injection prior month or needle sharing past 6 months....
There are an estimated 3.5 million people with hepatitis C virus (HCV) infection in the United States, resulting 15 000 HCV-related deaths 2019 and approximately $7 billion annually healthcare costs. Although States had experienced declining incidence, since 2010 infections have rebounded. The history of HCV treatment can be seen as a series scientific triumphs that should celebrated accomplishments they represent. But new treatments will only get us so far: Social determinants health drive...
Abstract Background Of 3.5 million people living with HCV in the US, nearly 60% are who inject drugs (PWID). Despite availability of a cure for HCV, uptake remains low PWID. We set out to study social determinants health (SDOH) that impact care cascade. Methods conducted secondary analysis baseline data from 720 PWID cluster-randomized trial. recruited via an outreach van 12 drug-affected areas Baltimore City. Inclusion criteria included injection prior month or needle sharing past 6 months....